A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : Dsg / desmoglein

[Related PubMed/MEDLINE]
Total Number of Papers: 210
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   Dsg  (>> Co-occurring Abbreviation)
Long Form:   desmoglein
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 A potential link between desmoglein 3 and epidermal growth factor receptor in oral squamous cell carcinoma and its effect on cetuximab treatment efficacy. EGFR, OSCC
2019 Herpetiform pemphigus with characteristic transmission electron microscopic findings of various-sized ballooning vacuoles in keratinocytes without acantholysis. HP, TEM
2018 Atomic Force Microscopy Provides New Mechanistic Insights into the Pathogenesis of Pemphigus. AFM
2018 Desmoglein 2, but not desmocollin 2, protects intestinal epithelia from injury. CD, Dsc, DSS
2018 Desmogleins as signaling hubs regulating cell cohesion and tissue/organ function in skin and heart - EFEM lecture 2018. AC
2018 Diagnosis of autoimmune bullous diseases. AIBDs, IF
2018 Diagnostik blasenbildender Autoimmundermatosen. BAIDs, IF-Mikroskopie
2018 E-cadherin binds to desmoglein to facilitate desmosome assembly. Dsc, E-cad
2018 Immunoadsorption of Desmoglein-3-Specific IgG Abolishes the Blister-Inducing Capacity of Pemphigus Vulgaris IgG in Neonatal Mice. PV
10  2018 Keratin Retraction and Desmoglein3 Internalization Independently Contribute to Autoantibody-Induced Cell Dissociation in Pemphigus Vulgaris. CK-1, PV
11  2018 Keratins Regulate p38MAPK-Dependent Desmoglein Binding Properties in Pemphigus. Ab, KtyII k.o, PF, WT
12  2018 Keratins Regulate the Adhesive Properties of Desmosomal Cadherins through Signaling. ---
13  2018 New biochip immunofluorescence test for the serological diagnosis of pemphigus vulgaris and foliaceus: A review of the literature. DIF, ELISA, IIF, PF, PV
14  2018 Ultrastructural changes in endometrial desmosomes of desmoglein 2 mutant mice. Dsc, Dsp
15  2017 Analysis of immunological profile, clinical features and response to treatment in pemphigus. ---
16  2017 Conjunctiva derived mesenchymal stem cell (CJMSCs) as a potential platform for differentiation into corneal epithelial cells on bioengineered electrospun scaffolds. CJMSCs, CK, Dsc, ICC, PU
17  2017 Different signaling patterns contribute to loss of keratinocyte cohesion dependent on autoantibody profile in pemphigus. PF, PV
18  2017 Divergent Specificity Development of IgG1 and IgG4 Autoantibodies in Endemic Pemphigus Foliaceus (Fogo Selvagem). FS
19  2017 Inhibition of p38MAPK signalling prevents epidermal blistering and alterations of desmosome structure induced by pemphigus autoantibodies in human epidermis. p38 MAPK, PV
20  2016 Analyses of Gingival Adhesion Molecules in Periodontitis: Theoretical In Silico, Comparative In Vivo, and Explanatory In Vitro Models. Dsc, HNP-1, OCLN
21  2016 Epitope analysis of antidesmoglein 1 autoantibodies from patients with pemphigus foliaceus across different activity stages. EC, EDTA, ELISA, PF, PV
22  2016 Family study of monozygotic twins affected by pemphigus vulgaris. PV
23  2016 Immune response in pemphigus and beyond: progresses and emerging concepts. HLA, PF, PV
24  2016 Increased Frequency of T Follicular Helper Cells and Elevated Interleukin-27 Plasma Levels in Patients with Pemphigus. APC, autoAb, MG, Tfh, Th
25  2016 Increased oxidative stress in pemphigus vulgaris is related to disease activity and HLA-association. BP, PV, TAC
26  2016 Monopathogenic vs multipathogenic explanations of pemphigus pathophysiology. KCs
27  2016 Multiplexed autoantigen microarrays identify HLA as a key driver of anti-desmoglein and -non-desmoglein reactivities in pemphigus. autoAbs, PV
28  2016 Nuclear magnetic resonance titration of the interaction between pemphigus vulgaris autoantibodies and REWVKFAKPCRE, a therapeutic desmoglein 3 peptide. NMR, PV
29  2016 Pathogenicity and Epitope Characteristics Do Not Differ in IgG Subclass-Switched Anti-Desmoglein 3 IgG1 and IgG4 Autoantibodies in Pemphigus Vulgaris. EC, mAbs, PV
30  2016 Pemphigus with features of both vulgaris and foliaceus variants localized to the nose. ---
31  2016 Reengineering chimeric antigen receptor T cells for targeted therapy of autoimmune disease. BCR, CAAR, PV
32  2016 Serum and salivary IgG and IgA antibodies to desmoglein 3 in mucosal pemphigus vulgaris. ELISA, PV
33  2016 Two cases of erosive oral lichen planus with autoantibodies to desmoglein 3. ELISA, erosive OLP, IF, Ig, OLP, PV
34  2015 Clues to diagnosis for unusual mucosal pemphigus demonstrating undetectable anti-desmoglein 3 serum antibodies by routine tests. ELISA, Ig, PV
35  2015 Immune cellular regulation on autoantibody production in pemphigus. ---
36  2015 Loss of Desmoglein Binding Is Not Sufficient for Keratinocyte Dissociation in Pemphigus. AFM, beta-MCD, PV
37  2015 Low pathogenicity of anti-desmoglein 3 immunoglobulin G autoantibodies contributes to the atypical clinical phenotypes in pemphigus. cPV, Ig
38  2015 Mucosal pemphigus vulgaris anti-Dsg3 IgG is pathogenic to the oral mucosa of humanized Dsg3 mice. hDSG3, IF, mcPV, mDsg3, PV, WT
39  2015 Oral lichen planus with antibodies to desmogleins 1 and 3. ELISA, LP
40  2015 Preclinical studies identify non-apoptotic low-level caspase-3 as therapeutic target in pemphigus vulgaris. PARP, PV
41  2015 Sgk1 regulates desmoglein 1 expression levels in oligodendrocytes in the mouse corpus callosum after chronic stress exposure. DSC1, Ndrg1
42  2015 Simultaneous immunolocalization of desmoglein 3 and IgG4 in oral pemphigus vulgaris: IgG4 predominant autoantibodies in its pathogenesis. PV
43  2015 Usefulness of specific anti-desmoglein 1 and 3 enzyme-linked immunoassay and indirect immunofluorescence in the evaluation of pemphigus activity. ELISA, IIF, PF, PV, ROC
44  2014 A desmoplakin point mutation with enhanced keratin association ameliorates pemphigus vulgaris autoantibody-mediated loss of cell cohesion. DP, PKC, PV
45  2014 Adducin is required for desmosomal cohesion in keratinocytes. PV
46  2014 Clinical and immunological outcomes of high- and low-dose rituximab treatments in patients with pemphigus: a randomized, comparative, observer-blinded study. ELISAs
47  2014 Desmosomal cadherins and signaling: lessons from autoimmune disease. ---
48  2014 Different roles of cadherins in the assembly and structural integrity of the desmosome complex. Dsc
49  2014 Insights into desmosome biology from inherited human skin disease and cardiocutaneous syndromes. ---
50  2014 Locations of acantholysis in pemphigus vulgaris and pemphigus foliaceus. PF, PV
51  2014 Nanorobotic investigation identifies novel visual, structural and functional correlates of autoimmune pathology in a blistering skin disease model. ---
52  2014 Specific immunoadsorption of pathogenic autoantibodies in pemphigus requires the entire ectodomains of desmogleins. PF, PV
53  2013 Clinical and immunological profile of umbilical involvement in pemphigus vulgaris and pemphigus foliaceus. PF, PV
54  2013 Desmoglein 2 is less important than desmoglein 3 for keratinocyte cohesion. Dsc, PV
55  2013 E-cadherin autoantibody profile in patients with pemphigus vulgaris. ELISAs, IP-WB, mcPV, mPV, PV
56  2013 Ectopic expression of epidermal antigens renders the lung a target organ in paraneoplastic pemphigus. PNP
57  2013 Endemic pemphigus foliaceus in the Peruvian Amazon. EPF, IIF
58  2013 Evaluation of commercially available ELISA assays as a tool for monitoring and managing pemphigus patients: a prospective study. ELISA
59  2013 IgA pemphigus with paraneoplastic pemphigus-like clinical features showing IgA antibodies to desmoglein 1/3 and desmocollin 3, and IgG and IgA antibodies to the basement membrane zone. Dsc
60  2013 Neural nitric oxide synthase participates in pemphigus vulgaris acantholysis through upregulation of Rous sarcoma, mammalian target of rapamycin and focal adhesion kinase. EGFR, FAK, mTOR, nNOS, NO, PV
61  2013 p38 MAPK Signaling in Pemphigus: Implications for Skin Autoimmunity. p38 MAPK, PF, PV
62  2013 The mapping of linear B-cell epitope regions in the extracellular parts of the desmoglein 1 and 3 proteins: recognition of immobilized peptides by pemphigus patients' serum autoantibodies. ELISA, PF, PV
63  2013 Two cases of pemphigus vegetans with IgG anti-desmocollin 3 antibodies. cDNA, Dscs, ELISAs
64  2012 Comparison of immunological parameters in patients with pemphigus vulgaris following rituximab and IVIG therapy. IVIG, LTR, PV, RTX
65  2012 Desmosomal cadherins in zebrafish epiboly and gastrulation. DCs, Dsc, hpf
66  2012 Enrichment of total serum IgG4 in patients with pemphigus. PF, PV
67  2012 Pemphigus autoantibodies generated through somatic mutations target the desmoglein-3 cis-interface. EC1, PV
68  2012 Ultrastructure of acantholysis in pemphigus foliaceus re-examined from the current perspective. PF
69  2011 IgG-induced clustering of desmogleins 1 and 3 in skin of patients with pemphigus fits with the desmoglein nonassembly depletion hypothesis. PF, PV
70  2011 p38 MAPK activation is downstream of the loss of intercellular adhesion in pemphigus vulgaris. PV
71  2011 Retinoid Induces the Degradation of Corneodesmosomes and Downregulation of Corneodesmosomal Cadherins: Implications on the Mechanism of Retinoid-induced Desquamation. CDSN, Dsc, KLK, RA
72  2011 Staphylococcus pseudintermedius exfoliative toxin EXI selectively digests canine desmoglein 1 and causes subcorneal clefts in canine epidermis. exi
73  2011 The extent of desmoglein 3 depletion in pemphigus vulgaris is dependent on Ca(2+)-induced differentiation: a role in suprabasal epidermal skin splitting? PV
74  2010 Actin reorganization contributes to loss of cell adhesion in pemphigus vulgaris. CNF1, FRAP, PV-IgG
75  2010 Autoimmune and infectious skin diseases that target desmogleins. Dsc, ET
76  2010 Binding of pemphigus vulgaris IgG to antigens in desmosome core domains excludes immune complexes rather than directly splitting desmosomes. DPK, PV
77  2010 Expression analysis of desmosomal components of the novel canine epidermal keratinocyte cell line (MSCEK). ---
78  2010 Herpetiform pemphigus without anti-desmoglein 1/3 autoantibodies. Ig
79  2010 Immune dysregulation of pemphigus in humans and mice. Ig
80  2010 Immune response towards the amino-terminus of desmoglein 1 prevails across different activity stages in nonendemic pemphigus foliaceus. EC, PF
81  2010 Immunopathologic features of pemphigus in the east Mediterranean region of Turkey: a prospective study. CAS, DIF, ELISA, IF, IIF, PV
82  2010 Induction of hyper-adhesion attenuates autoimmune-induced keratinocyte cell-cell detachment and processing of adhesion molecules via mechanisms that involve PKC. CAR, PV
83  2010 Novel ELISA systems for antibodies to desmoglein 1 and 3: correlation of disease activity with serum autoantibody levels in individual pemphigus patients. PF, PV
84  2010 Pemphigus herpetiformis: analysis of the autoantibody profile during the disease course with changes in the clinical phenotype. PH
85  2010 Protective endogenous cyclic adenosine 5'-monophosphate signaling triggered by pemphigus autoantibodies. PV
86  2010 Removal of amino-terminal extracellular domains of desmoglein 1 by staphylococcal exfoliative toxin is sufficient to initiate epidermal blister formation. Dsc1-N, ETs
87  2010 Serum and salivary desmoglein 1 and 3 enzyme-linked immunosorbent assay in pemphigus vulgaris: correlation with phenotype and severity. ELISA, PV
88  2009 A single helper T cell clone is sufficient to commit polyclonal naive B cells to produce pathogenic IgG in experimental pemphigus vulgaris. ---
89  2009 Autoantibodies against desmocollins in European patients with pemphigus. Dsc, PNP, PV
90  2009 Clinical and immunological follow-up of pemphigus patients on adjuvant treatment with immunoadsorption or rituximab. IA, PV, RTX
91  2009 Desmocollin 3-mediated binding is crucial for keratinocyte cohesion and is impaired in pemphigus. AFM, Dsc
92  2009 Desmoglein 3-specific T regulatory 1 cells consist of two subpopulations with differential expression of the transcription factor Foxp3. CTLA-4, FACS, GITR, IL, PV, TCR, TGF, Tr1
93  2009 Disruption of desmosome assembly by monovalent human pemphigus vulgaris monoclonal antibodies. Dsc, PV
94  2009 Lesions of pemphigus vulgaris on irradiated skin. PV
95  2009 Pemphigus vulgaris IgG cause loss of desmoglein-mediated adhesion and keratinocyte dissociation independent of epidermal growth factor receptor. EGF, EGFR, PV
96  2009 Pemphigus: the promises of peptide immunotherapy. ---
97  2009 Peptides Targeting the Desmoglein 3 Adhesive Interface Prevent Autoantibody-induced Acantholysis in Pemphigus. PV, TP
98  2009 Protein kinase C isoenzymes differentially regulate the differentiation-dependent expression of adhesion molecules in human epidermal keratinocytes. PKC
99  2009 The molecular logic of pemphigus and impetigo: the desmoglein story. ---
100  2009 Update on the cloning of monoclonal anti-desmoglein antibodies from human pemphigus patients: implications for targeted therapy. mAbs, PF